20660507

Source:http://linkedlifedata.com/resource/pubmed/id/20660507

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0041714, umls-concept:C0289313, umls-concept:C1553387, umls-concept:C1948035
pubmed:dateCreated	2010-7-27
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8900488
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones, http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
pubmed:status	MEDLINE
pubmed:issn	1468-5833
pubmed:author	pubmed-author:CohenDeborahD
pubmed:issnType	Electronic
pubmed:volume	341
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	c4017
pubmed:meshHeading	pubmed-meshheading:20660507-Clinical Trials as Topic, pubmed-meshheading:20660507-Humans, pubmed-meshheading:20660507-Hypoglycemic Agents, pubmed-meshheading:20660507-Safety-Based Drug Withdrawals, pubmed-meshheading:20660507-Thiazolidinediones, pubmed-meshheading:20660507-United States, pubmed-meshheading:20660507-United States Food and Drug Administration
pubmed:year	2010
pubmed:articleTitle	FDA puts rosiglitazone post-marketing trial on hold.
pubmed:publicationType	News